Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Corrigendum to "Glucagon-like Peptide 1 Agonist Use in an Adult With Cystic Fibrosis-Related Diabetes and Metabolic Syndrome": [AACE Endocrinology and Diabetes 12 (2025) 67-70].
Journal: AACE endocrinology and diabetes
Published: April 06, 2026
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Cardiopulmonary Exercise Testing in Adults with Cystic Fibrosis: A Retrospective Study.
Journal: Annals of the American Thoracic Society
Published: August 07, 2025
Improving Inpatient Cystic Fibrosis Exacerbation Care: A Resident Physician Training Approach.
Journal: Rhode Island medical journal (2013)
Published: March 27, 2025
Glucagon-Like Peptide 1 Agonist Use in an Adult With Cystic Fibrosis-Related Diabetes and Metabolic Syndrome.
Journal: AACE endocrinology and diabetes
Published: February 07, 2025
Emerging pharmacotherapies for the treatment of pulmonary arterial hypertension.
Journal: Expert opinion on investigational drugs
Published: October 26, 2023
Perceptions and Use of E-cigarettes among Young Adults with Cystic Fibrosis: An Observational Study.
Perceptions and Use of E-cigarettes among Young Adults with Cystic Fibrosis: An Observational Study.
Journal: Rhode Island medical journal (2013)
Published: July 26, 2023
Integrating Primary Care into the Management of Cystic Fibrosis.
Journal: Journal of primary care & community health
Published: May 09, 2023
Updates on the Management of Cystic Fibrosis: Development of Modulators and Advancement of Antibiotic Therapies.
Journal: Rhode Island medical journal (2013)
Published: August 26, 2021
Things We Do for No Reason™: Routine use of corticosteroids for the treatment of anaphylaxis.
Journal: Journal of hospital medicine
Published: March 21, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026